Dunn Medicine

About:

Dunn Medicine is a clinical precision medication guidance service provider.

Website: https://www.dunen.net/index.html

Top Investors: CICC, Jingyao Fund

Description:

Dunn Medicine is a clinical precision medication guidance service provider. The company mainly focuses on rational drug use. To this end, it focuses on building molecular platforms and mass spectrometry platforms. Its molecular platforms include fluorescence quantitative PCR instruments, illumina second-generation sequencers, and ABI first-generation sequencers.

Total Funding Amount:

100M CNY

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2017-01-01

Contact Email:

postmaster(AT)dunen.net

Founders:

Number of Employees:

51-100

Last Funding Date:

2024-02-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai